scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1039005211 |
P356 | DOI | 10.1038/SREP16355 |
P932 | PMC publication ID | 4817527 |
P698 | PubMed publication ID | 26549310 |
P5875 | ResearchGate publication ID | 284104169 |
P2093 | author name string | Jing Yang | |
Bin Li | |||
Lei Han | |||
Xiuwen Wang | |||
Peng Xu | |||
Zuojia Chen | |||
Andy Tsun | |||
Yayi Gao | |||
Jia Nie | |||
Ling Lv | |||
Jijia Shen | |||
Qingsi Wu | |||
Qijuan Sun | |||
P2860 | cites work | Sirtuin inhibitor Ex-527 causes neural tube defects, ventral edema formations, and gastrointestinal malformations in Xenopus laevis embryos. | Q50640761 |
A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses | Q60035686 | ||
FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression | Q24300168 | ||
SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53 | Q24310032 | ||
The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes | Q24321949 | ||
Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1 | Q24336199 | ||
Acetylation of Sirt2 by p300 attenuates its deacetylase activity | Q24336353 | ||
USP22 is a positive regulator of NFATc2 on promoting IL2 expression | Q24338120 | ||
Negative and positive regulation of gene expression by mouse histone deacetylase 1 | Q24672508 | ||
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain | Q27860534 | ||
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3 | Q28118511 | ||
Control of Smad7 stability by competition between acetylation and ubiquitination | Q28212409 | ||
HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention | Q28240437 | ||
TH17 cells in development: an updated view of their molecular identity and genetic programming | Q28276449 | ||
The SIRT2 deacetylase regulates autoacetylation of p300 | Q28300323 | ||
T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma | Q28506783 | ||
A validated regulatory network for Th17 cell specification | Q28586624 | ||
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages | Q29547871 | ||
Modes of p53 regulation | Q29615657 | ||
IL-17 family cytokines and the expanding diversity of effector T cell lineages | Q29619361 | ||
IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. | Q30439073 | ||
MeCP2 enforces Foxp3 expression to promote regulatory T cells' resilience to inflammation | Q33919580 | ||
Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3. | Q34089148 | ||
The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor γt (RORγt) in Th17 cells | Q34170660 | ||
Polyubiquitination of p53 by a ubiquitin ligase activity of p300. | Q34190044 | ||
Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). | Q34520098 | ||
RORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis | Q34613664 | ||
The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis | Q34636005 | ||
CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. | Q35006610 | ||
Transcription of Il17 and Il17f is controlled by conserved noncoding sequence 2. | Q35724805 | ||
Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK | Q35749976 | ||
Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells | Q36652900 | ||
Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos | Q36777934 | ||
60-kDa Tat-interactive protein (TIP60) positively regulates Th-inducing POK (ThPOK)-mediated repression of eomesodermin in human CD4+ T cells | Q36890566 | ||
Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism | Q36929766 | ||
Identification of IL-17-producing FOXP3+ regulatory T cells in humans. | Q37122868 | ||
Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunity. | Q37222190 | ||
Nicotinamide: a class III HDACi delays in vitro aging of mouse oocytes | Q37602097 | ||
Histone deacetylase inhibitors modulate interleukin 6-dependent CD4+ T cell polarization in vitro and in vivo | Q37608561 | ||
Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors | Q37687716 | ||
Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment | Q37708759 | ||
Physical and functional HAT/HDAC interplay regulates protein acetylation balance | Q37820140 | ||
Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. | Q39765588 | ||
Trichostatin A promotes the generation and suppressive functions of regulatory T cells | Q40964294 | ||
Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases | Q41128716 | ||
Deacetylase inhibitor trichostatin A down-regulates Foxp3 expression and reduces CD4+CD25+ regulatory T cells | Q42923536 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 16355 | |
P577 | publication date | 2015-11-09 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Reciprocal regulation of RORγt acetylation and function by p300 and HDAC1. | |
P478 | volume | 5 |
Q64118226 | Antagonizing Retinoic Acid-Related-Orphan Receptor Gamma Activity Blocks the T Helper 17/Interleukin-17 Pathway Leading to Attenuated Pro-inflammatory Human Keratinocyte and Skin Responses |
Q92072015 | Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate |
Q58747685 | GLK-IKKβ signaling induces dimerization and translocation of the AhR-RORγt complex in IL-17A induction and autoimmune disease |
Q57143889 | Histone deacetylase function in CD4 T cells |
Q64914861 | Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy. |
Q89725150 | JQ1, a bromodomain inhibitor, suppresses Th17 effectors by blocking p300-mediated acetylation of RORγt |
Q48098684 | Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics. |
Q47097758 | Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo. |
Q26740155 | Post-translational regulation of RORγt-A therapeutic target for the modulation of interleukin-17-mediated responses in autoimmune diseases |
Q55354251 | Quantitative proteomic characterization and comparison of T helper 17 and induced regulatory T cells. |
Q43523326 | Regulation of Th17 Differentiation by IKKα-Dependent and -Independent Phosphorylation of RORγt |
Q58097712 | SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2 |
Q57712790 | Targeting transcription factor lysine acetylation in inflammatory airway diseases |
Q39015080 | Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders. |
Search more.